Randomized controlled clinical trial on calcium phosphate coated and conventional SLA surface implants: 1‐year study on survival rate and marginal bone level

2019 ◽  
Vol 21 (5) ◽  
pp. 995-1001
Author(s):  
Kyung‐A Ko ◽  
Seungmin Kim ◽  
Seong‐Ho Choi ◽  
Jung‐Seok Lee
Keyword(s):  
Clinical Trial ◽  
Survival Rate ◽  
Calcium Phosphate ◽  
Controlled Clinical Trial ◽  
Randomized Controlled Clinical Trial ◽  
Randomized Controlled ◽  
Bone Level ◽  
Marginal Bone Level

Clinical evaluation of narrow diameter implants versus standard diameter implants with bone augmentation in posterior jaws:study protocol for a randomized controlled clinical trial

2019 ◽  
Author(s):  
Shujiao Qian ◽  
Shichong Qiao ◽  
Yu Zhu ◽  
Xiao Zhang ◽  
Jiaji Mo
Keyword(s):  
Clinical Trial ◽  
Survival Rate ◽  
Clinical Efficacy ◽  
Posterior Region ◽  
Controlled Clinical Trial ◽  
Bone Augmentation ◽  
Randomized Controlled Clinical Trial ◽  
Randomized Controlled ◽  
Bone Width ◽  
Narrow Diameter Implants

Abstract Background: Nowadays, narrow diameter implants are being increasingly used in posterior regions with insufficient bone width to avoid invasive bone augmentation procedures. Recent studies have indicated that narrow implants with a diameter of 3.3 to 3.5mm showed comparable survival rate with standard diameter implants. However, there are no high-quality clinical trials comparing the clinical outcomes of narrow diameter implants to standard diameter implants with augmentation procedures in atrophic posterior region. The purpose of present study is to evaluate the clinical efficacy of narrow diameter implants in posterior jaws. Methods/Design: This study is designed as a prospective, single-center, 2-arm parallel, randomized controlled clinical trial. Patients in need of single implant crowns in posterior jaws will be included in the study according to clear defined inclusion-and-exclusion criteria. Randomized number table will be used to assign the patients into two groups: group 1: narrow diameter implant group (NDI); group 2: standard diameter implant with bone augmentation group (SDI). Implant survival rate, mechanical complications, marginal bone loss, peri-implant conditions and patients’ satisfaction will be recorded. Clinical and radiological re-evaluations will be performed at 6, 12, 36, 60 months after the final crowns delivery. Discussion: Our findings will help evaluate the clinical efficacy of narrow implant in posterior region. If the results were favorable, narrow implants might be recommended as a viable alternative for posterior region with insufficient bone width. Trial registration: Clinicaltrials.gov identifier: ChiCTR1800020426 (registered on 29 December 2018)

scholarly journals Treatment of Periimplantitis - Electrolytic Cleaning versus Mechanical and Electrolytic Cleaning - A Randomized Controlled Clinical Trial – 18 Months Results

2021 ◽  
Author(s):  
Markus Schlee ◽  
Hom-Lay Wang ◽  
Thomas Stumpf ◽  
Urs Brodbeck ◽  
Florian Rathe
Keyword(s):  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Clinical Parameters ◽  
Regenerative Therapy ◽  
Randomized Controlled Clinical Trial ◽  
Pocket Depth ◽  
Randomized Controlled ◽  
Probing Pocket Depth ◽  
Bone Level ◽  
Bone To Implant Contact

Background: this RCT assesses the 18 months clinical outcomes after regenerative therapy of periimplantitis lesions using either an electrolytic method (EC) to remove biofilms or a combination of powder spray and electrolytic method (PEC). Materials and Methods: Twenty-four patients (24 implants) suffering from periimplantitis were randomly treated by EC or PEC followed by augmentation and submerged healing. Probing pocket depth (PPD), Bleeding on Probing (BoP), suppuration and standardized radiographs were assessed before surgery (T0), 6 months after augmentation (T1), 6 (T2) and 12 (T3) months after replacement of the restoration. Results: Mean of PPD changed from 5.8 ± 1.6 mm (T0) to 3.1 ± 1.4 mm (T3). While BoP and suppuration at T0 was 100 % BoP decreased at T2 to 36.8 % and at T3 to 35.3 %. Suppuration could be found 10.6% at T2 and 11.8% at T3. Radiologic bone level measured from the implant shoulder to the first visible bone to implant contact was 4.9 ± 1.9 mm at me-sial and 4.4 ± 2.2 mm at distal sites (T0) and 1.7 ± 1.7 mm and 1.5 ± 17 mm at T3. Conclusions: Significant radiographic bone fill and improvement of clinical parameters were demonstrated 18 months after therapy.

scholarly journals Treatment of Periimplantitis with Electrolytic Cleaning versus Mechanical and Electrolytic Cleaning: 18-Month Results from a Randomized Controlled Clinical Trial

2021 ◽  
Vol 10 (16) ◽  
pp. 3475
Author(s):  
Markus Schlee ◽  
Hom-Lay Wang ◽  
Thomas Stumpf ◽  
Urs Brodbeck ◽  
Dieter Bosshardt ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Clinical Parameters ◽  
Regenerative Therapy ◽  
Randomized Controlled Clinical Trial ◽  
Pocket Depth ◽  
Randomized Controlled ◽  
Probing Pocket Depth ◽  
Bone Level ◽  
The Mean

Aim of the study: This RCT assesses patients’ 18-month clinical outcomes after the regenerative therapy of periimplantitis lesions using either an electrolytic method (EC) to remove biofilms or a combination of powder spray and an electrolytic method (PEC). Materials and Methods: Twenty-four patients (24 implants) suffering from periimplantitis were randomly treated by EC or PEC followed by augmentation and submerged healing. Probing pocket depth (PPD), Bleeding on Probing (BoP), suppuration, and standardized radiographs were assessed before surgery (T0), 6 months after augmentation (T1), and 6 (T2) and 12 (T3) months after the replacement of the restoration. Results: The mean PPD changed from 5.8 ± 1.6 mm (T0) to 3.1 ± 1.4 mm (T3). While BoP and suppuration at T0 were 100%, BoP decreased at T2 to 36.8% and at T3 to 35.3%. Suppuration was found to be at a level of 10.6% at T2 and 11.8% at T3. The radiologic bone level measured from the implant shoulder to the first visible bone to the implant contact was 4.9 ± 1.9 mm at mesial sites and 4.4 ± 2.2 mm at distal sites at T0 and 1.7 ± 1.7 mm and 1.5 ± 17 mm at T3. Conclusions: Significant radiographic bone fill and the improvement of clinical parameters were demonstrated 18 months after therapy.

Sign in / Sign up

Export Citation Format

Share Document